The Role of Injectable Platelet-Rich Fibrin in Orthopedics: Where Do We Stand?
Current Issues in Molecular Biology · 29.03.2025 · 47 (4) · 239
DOI: 10.3390/cimb47040239 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 29.03.2025. Verfasst von Fábio Ramos Costa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, FC Sports Traumatology, Salvador 40296-210, BA, Brazil. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Injectable Platelet-Rich Fibrin (i-PRF) has emerged as a promising tool in regenerative medicine, particularly in orthopedics, due to its unique biological properties and ease of preparation. i-PRF is an autologous platelet concentrate derived through a simple, anticoagulant-free centrifugation process, resulting in a liquid matrix enriched with fibrin, leukocytes, and growth factors. These components promote tissue regeneration, angiogenesis, and anti-inflammatory responses, making i-PRF suitable for bone and cartilage repair as well as drug delivery systems. This review discusses the history, biological mechanisms, and clinical applications of i-PRF in orthopedics, highlighting its potential advantages over traditional platelet-rich plasma (PRP). Furthermore, we address the challenges and limitations of i-PRF, including drug stability, release control, and bioactive interactions, underscoring the need for further research to optimize its therapeutic efficacy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedics, FC Sports Traumatology, Salvador 40296-210, BA, Brazil.
- Department of Radiology, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-916, RJ, Brazil.
- Medical School, Tiradentes University Center, Maceió 57038-000, AL, Brazil.
- Medical School, Zarns College, Salvador 41720-200, BA, Brazil.
- Department of Orthopedics, Brazilian Institute of Regenerative Medicine (BIRM), Indaiatuba 13334-170, SP, Brazil.
- Regenerative Medicine, Orthoregen International Course, Indaiatuba 13334-170, SP, Brazil.
ORCID-Profile: Fábio Ramos Costa, Sergio Augusto Lopes de Souza, Rubens Andrade Martins, Luyddy Pires, Alex Pontes de Macedo, Napoliane Santos, André Kruel
Zitieren
APA
Costa, F. R., de Souza, S. A. L., Martins, R. A., Costa, B. R., Pires, L., de Macedo, A. P., Santos, N., Huber, S. C., Santos, G. S., Kruel, A., Santos, M., & Lana, J. F. (2025). The Role of Injectable Platelet-Rich Fibrin in Orthopedics: Where Do We Stand?. Current Issues in Molecular Biology, 47(4), 239. https://doi.org/10.3390/cimb47040239
Vancouver
Costa FR, de Souza SAL, Martins RA, Costa BR, Pires L, de Macedo AP, et al. The Role of Injectable Platelet-Rich Fibrin in Orthopedics: Where Do We Stand?. Current Issues in Molecular Biology. 2025;47(4):239. doi:10.3390/cimb47040239
BibTeX
@article{Costa2025,
author = {Costa, Fábio Ramos and de Souza, Sergio Augusto Lopes and Martins, Rubens Andrade and Costa, Bruno Ramos and Pires, Luyddy and de Macedo, Alex Pontes and Santos, Napoliane and Huber, Stephany Cares and Santos, Gabriel Silva and Kruel, André and Santos, Márcia and Lana, José Fábio},
title = {The Role of Injectable Platelet-Rich Fibrin in Orthopedics: Where Do We Stand?},
journal = {Current Issues in Molecular Biology},
year = {2025},
volume = {47},
number = {4},
pages = {239},
doi = {10.3390/cimb47040239}
}
EUVIMED